Sean M Devlin

24PUBLICATIONS
151CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Nov 18, 2025
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impact.

Magdalena Corona, Samantha Brown, Kai Rejeski

|Oct 04, 2025
Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host disease.

Gagan Raju, Moneeza Walji, David Nemirovsky

|Jul 03, 2025
Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States.

Curtis A Lachowiez, Georgios Asimomitis, Elsa Bernard

|Jul 02, 2025
Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies.

Sigrun Einarsdottir, Stephanie Lobaugh, Danny Luan

|Apr 14, 2025
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma.

Alejandro Luna, Sean M Devlin, Kai Rejeski

|Jan 30, 2025
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma.

Jae H Park, M Lia Palomba, Karlo Perica

Pageof 4

Frequent Collaborators

11 joint publications

Miguel-Angel Perales

9 joint publications

Richard Lin

8 joint publications

Maria Lia Palomba

8 joint publications

Gilles Salles